Stay updated on Nivolumab and HPV-16 Vaccine for Incurable Solid Tumors Clinical Trial

Sign up to get notified when there's something new on the Nivolumab and HPV-16 Vaccine for Incurable Solid Tumors Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab and HPV-16 Vaccine for Incurable Solid Tumors Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    The ClinicalTrials.gov page remains a 403 Forbidden error screen, with the footer revision label changing from v3.7.2 to v3.8.0.
    Difference
    0.2%
    Check dated 2026-11-01T15:48:35.000Z thumbnail image
  2. Check
    8 days ago
    Change Detected
    Summary
    A banner announces NIH website transition updates and says NIH content may use “Super Intelligence” instead of “Artificial Intelligence” during the transition.
    Difference
    1%
    Check dated 2026-10-25T17:21:20.000Z thumbnail image
  3. Check
    15 days ago
    Change Detected
    Summary
    The footer revision label changes from v3.7.1 to v3.7.2 while the page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-18T22:21:18.000Z thumbnail image
  4. Check
    22 days ago
    Change Detected
    Summary
    The site footer revision number changes from v3.7.0 to v3.7.1.
    Difference
    0.2%
    Check dated 2026-10-11T22:06:31.000Z thumbnail image
  5. Check
    43 days ago
    Change Detected
    Summary
    The page now shows a 403 Forbidden error, replacing the study details with a standard error page; access to the NCT02426892 study record is blocked.
    Difference
    19%
    Check dated 2026-09-20T22:24:15.000Z thumbnail image
  6. Check
    64 days ago
    Change Detected
    Summary
    The page revision label was updated from v3.6.5 to v3.6.6, indicating a minor update to the page or site. This change reflects versioning rather than substantive content changes to the study details.
    Difference
    0.1%
    Check dated 2026-08-30T21:38:16.000Z thumbnail image

Stay in the know with updates to Nivolumab and HPV-16 Vaccine for Incurable Solid Tumors Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab and HPV-16 Vaccine for Incurable Solid Tumors Clinical Trial page.